Valneva SE (VALN) Current Leases (2020 - 2025)
Valneva SE's (VALN) quarterly Current Leases came in at $3.2 million in Q4 2025, up 18.97% year-on-year from $2.7 million in Q4 2024, and up 18.97% quarter-over-quarter from $2.7 million in Q4 2024.
Valneva SE (VALN) Current Leases (2020 - 2025) Analysis & Trends
Valneva SE has disclosed Current Leases across 6 years of filings, most recently posting $3.2 million for Q4 2025.
- Current Leases for Q4 2025 came in at $3.2 million, up 18.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 million (up 18.97% YoY), and the FY2025 annual result was $3.2 million, up 18.97% from the prior year.
- Current Leases came in at $3.2 million for Q4 2025 at Valneva SE, up from $2.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $25.9 million in Q4 2022 to a low of $2.7 million in Q4 2024.
- The 5-year median for Current Leases is $3.2 million (2025), against an average of $7.7 million.
- Across the five-year window, Current Leases soared 622.89% in 2022 and tumbled 88.05% in 2023, its largest moves.
- Valneva SE's Current Leases stood at $3.6 million in 2021, then jumped by 622.89% to $25.9 million in 2022, then sank by 88.05% to $3.1 million in 2023, then fell by 13.48% to $2.7 million in 2024, then grew by 18.97% to $3.2 million in 2025.
- The last three Current Leases figures came in at $3.2 million (Q4 2025), $2.7 million (Q4 2024), and $3.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Dec 31, 2022 | 25.93 Mn |
| Dec 31, 2021 | 3.59 Mn |
| Dec 31, 2020 | 3.21 Mn |